Sweden's Sobi says terminates takeover talks

STOCKHOLM, June 8 (Reuters) - Swedish rare diseases drugmaker Swedish Orphan Biovitrum (Sobi) said on Monday it had terminated discussions regarding a non-binding proposal in relation to a possible offer for the company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.